economic

Economic Burden

The cost of fibromyalgia to both the individual and to society is extensive. A 2007 study found that 34% of fibromyalgia patients spend between $100- $1,000 per month above their insurance to see a healthcare professional. Prominent fibromyalgia researchers and specialists estimate the costs in the U.S. between $12-14 billion each year and accounts for a loss of 1-2% of the nation’s overall productivity.

According to a 2003 published study in the Journal of Rheumatology:

  • The total annual costs for fibromyalgia claimants were more than twice as high as the costs for the typical insurance beneficiary.

  • The prevalence of disability among employees with fibromyalgia was twice as high as among all employees.

  • For every dollar spent on fibromyalgia specific claims, employers spent approximately $50 -$100 on additional direct and indirect costs.

Additional studies show:

  • Work and disability status of 1,668 FM patients reported that 25% had received disability payments. (Wolf, J Musculoskelet Pain. 1993)

  • Failure to diagnose a true case of fibromyalgia has its own costs, largely in excess general practitioner visits, investigations and prescriptions. (Annemans, Arthritis & Rheumatism. March 2008.)

  • Use of complementary and alternative medicine is 2 ? times higher in FM patients. (Lind, Arthritis & Rheumatism. February 2007.)

  •  In 2012 the NFA in conjunction with Health Focus, Inc. conducted a study exploring the out-of-pocket expenditures for treatment. The following table depicts the studies outcomes:

eco